HPV Vaccine Scotland 2026: A Calm NHS-Aligned Guide to the One-Dose Schedule, School Programme and Adult Catch-Up

Public Health Scotland reported in January 2024 that no cervical cancer cases had been detected in women fully vaccinated through Scotland’s school-based programme since vaccination began in 2008. Scotland delivers Gardasil 9 as a single free dose in S1 to both boys and girls, with free catch-up to age 25.

Scotland was one of the earliest adopters of HPV vaccination and is now widely considered one of the countries closest to eliminating cervical cancer. The vaccine programme has changed several times since it began in 2008, and parents and students in 2026 often want to know what the current schedule actually looks like. This article explains exactly that.

It covers who is eligible, what the single-dose Gardasil 9 schedule involves, why both boys and girls now receive the vaccine, what the most recent Public Health Scotland coverage and effectiveness data show, and how to get a free catch-up dose if you missed the school appointment. It is written from a calm GP-clinic perspective, with answers to the most common questions parents and young people raise. The aim is information, not pressure. If you have already missed your dose and want to know how to arrange one, the catch-up section below explains the steps.

What the HPV vaccine programme in Scotland looks like in 2026

The current Scottish HPV vaccination programme is delivered free of charge through the NHS, with the main route being a school-based offer to all S1 pupils aged 11 to 13. The vaccine in use is Gardasil 9, a non-live vaccine that protects against nine HPV types: 6, 11, 16, 18, 31, 33, 45, 52 and 58. Between them these types cause approximately 87 per cent of cervical cancers and a substantial share of throat, anal, penile, vulval, vaginal and mouth cancers.

Two important changes have happened in recent years. First, in 2022 Scotland moved from the previous four-valent vaccine to the nine-valent Gardasil 9. Second, in 2023 Scotland adopted a one-dose schedule for the routine school programme, in line with JCVI and WHO advice. Before then two doses had been standard. Both boys and girls in S1 receive the single dose.

Public Health Scotland statistics for the 2024-25 school year showed S1 coverage of 72.6 per cent, up from 71.5 per cent the previous year. NHS immunisation teams attend Scottish secondary schools during the autumn and spring terms to deliver the vaccine, with parental consent forms sent in advance. Pupils who miss the school session for any reason are followed up. Anyone in Scotland who has missed the school programme can request a free catch-up dose up to the age of 25 by contacting their local NHS Board immunisation service via NHS Inform Scotland.

Why Scotland vaccinates both boys and girls

Boys were added to the Scottish HPV vaccination programme in 2019. The rationale is twofold. First, HPV causes cancers in men as well as in women. HPV is responsible for a substantial share of throat, anal, penile, mouth and tonsil cancers. Rates of HPV-related throat cancer have been rising in the UK for the last two decades, and vaccinating boys is the most effective way to prevent these cancers in future. Second, vaccinating boys contributes to herd immunity. HPV is a sexually transmitted infection and the more of the population that is protected, the lower the chances of any individual encountering an infectious partner. This protects unvaccinated people indirectly and is part of Scotland’s elimination strategy.

The Scottish Government’s Cervical Cancer Elimination Action Plan sets a clear goal of eliminating cervical cancer in Scotland, defined by WHO as fewer than four cases per 100,000 women each year. Achieving this depends on three pillars: high HPV vaccination coverage in both girls and boys, high uptake of cervical screening at the recommended ages, and timely treatment for pre-cancerous changes. Without vaccinating boys, herd immunity is much weaker and the elimination target is harder to reach.

Parents of boys sometimes ask whether the vaccine is really necessary if their son will not develop cervical cancer. The answer is that the vaccine protects the boy himself from several other HPV-related cancers in adulthood and protects his future partners through reduced community circulation.

The headline Scottish effectiveness data

In January 2024 Public Health Scotland reported a finding that has since been cited around the world. No cervical cancer cases had been detected in women fully vaccinated against HPV through Scotland’s school-based programme since vaccination began in 2008. The analysis looked at women born in 1988 onwards who had received a complete course of HPV vaccine in the early years of the Scottish programme. Cervical cancer cases were detected in unvaccinated women in the same birth cohorts. The vaccinated cohort showed zero detected cases at the point of analysis.

This is one of the strongest real-world effectiveness signals for any vaccine programme. Researchers at the University of Strathclyde published follow-up work in 2025 showing the vaccine continues to provide effective protection more than 12 years after the first dose, with no signs of waning immunity in this age group.

The effectiveness data underpin both the move to a single-dose schedule and the inclusion of boys. The Scottish Government and Public Health Scotland have been clear that this trajectory only continues if coverage stays high in incoming S1 cohorts. The 2024-25 coverage of 72.6 per cent is below the WHO elimination target of 90 per cent by age 15. Closing this gap is the focus of current public health communication, including school engagement, catch-up offers for those up to 25, and dedicated sexual health clinic routes for groups at higher risk.

How to get a free catch-up dose if you missed it

Free catch-up HPV vaccination is available in Scotland for anyone up to the age of 25 who has not yet received it. This includes those who missed the appointment in S1, those whose families declined at the time and have changed their mind, those who moved to Scotland from another country after their school year, and those who were absent from school during the year their cohort was vaccinated.

The route to access is your local NHS Board immunisation service. NHS Inform Scotland has contact details for each NHS Board across the country. Step one is to phone or email the immunisation team and explain that you would like to arrange a catch-up dose. They will arrange an appointment, often at a community clinic or at the school for current pupils. University immunisation teams visit Scottish universities each term to offer the vaccine to students who may have missed it. If you are a student, watch out for posters and updates from your university health service or the local NHS Board.

Gay and bisexual men, including trans men who have sex with men, up to the age of 45 are eligible for free HPV vaccination via sexual health clinics. Sandyford in Glasgow, Chalmers Centre in Edinburgh, and the equivalent services across NHS Highland, NHS Tayside and other Boards all offer this. People with HIV are eligible at any age. The same applies to specific immunosuppressed groups under specialist guidance.

What parents and young people most often ask

The most common parental question is whether 11 to 13 is too young to vaccinate against a sexually transmitted infection. The science is clear that the vaccine is most effective when given before any HPV exposure, which in practice means before any sexual activity. This is also when the immune response to the vaccine is strongest. Vaccinating in S1 protects a young person long before they need to think about that protection.

Robust studies in the UK, US, Sweden and Australia have looked at whether HPV vaccination is associated with earlier or more sexual activity in young people. They have consistently found no such association.

The single-dose schedule is another area of frequent questions. WHO, JCVI and the Scottish Chief Medical Officer have endorsed it on the basis of strong evidence that a single dose of Gardasil 9 produces protection equivalent to two- or three-dose schedules in this age group. This is why Scotland moved to the single dose in 2023.

Many parents also ask whether the vaccine replaces cervical screening. It does not. The Scottish cervical screening programme continues for all eligible women aged 25 to 64 because the vaccine does not cover every cancer-causing HPV type. A small number of side effects are typical of any intramuscular vaccine: a sore arm, mild headache or low-grade fever for a day or two. Gardasil 9 contains no live virus and cannot cause HPV infection. Severe allergic reactions are extremely rare and managed by trained NHS immunisation teams.

Frequently Asked Questions

Who is eligible for free HPV vaccination in Scotland in 2026?

All S1 pupils in Scotland aged 11 to 13, both boys and girls, are offered a free single dose of Gardasil 9 through the school-based NHS programme. Anyone in Scotland up to age 25 who missed the school appointment is eligible for free catch-up vaccination via the local NHS Board immunisation service. Gay and bisexual men up to age 45 are eligible via sexual health clinics. People with HIV are eligible at any age. Specific immunosuppressed groups are also eligible under specialist guidance.

Why does Scotland now use only one dose?

Scotland adopted a one-dose HPV schedule in 2023 in line with JCVI and WHO advice. Strong evidence shows that a single dose of nine-valent Gardasil 9 produces protection equivalent to two- or three-dose schedules in adolescents and young adults. The change makes the programme simpler to deliver, saves NHS resources, and means fewer appointments for young people. Scientific endorsement came from the Joint Committee on Vaccination and Immunisation and the Scottish Chief Medical Officer.

What does the Public Health Scotland zero-cervical-cancer finding actually mean?

Public Health Scotland reported in January 2024 that no cervical cancer cases had been detected in women fully vaccinated against HPV through the school-based programme since vaccination began in 2008. Cervical cancer cases were detected in unvaccinated women in the same birth cohorts. The finding has been widely cited as one of the strongest real-world effectiveness signals for any vaccination programme. A 2025 University of Strathclyde study confirmed sustained protection more than 12 years after vaccination.

How do I arrange catch-up HPV vaccination as an adult in Scotland?

Contact the immunisation team at your local NHS Board via NHS Inform Scotland. If you are under 25 and missed the school programme, the catch-up dose is free. Many universities run on-campus immunisation sessions each term. Gay and bisexual men up to age 45 can attend Sandyford in Glasgow, Chalmers in Edinburgh or the equivalent sexual health clinic in other NHS Boards for free HPV vaccination. Bring identification and any previous vaccination records to your appointment.

Will the HPV vaccine replace cervical screening in Scotland?

No. The Scottish cervical screening programme continues for all eligible women aged 25 to 64, whether they have been vaccinated or not. The vaccine reduces but does not eliminate cervical cancer risk because Gardasil 9 does not cover every cancer-causing HPV type. Screening detects pre-cancerous changes in the cervix at an early stage when they are easily treated. Vaccination and screening together form the basis of Scotland’s cervical cancer elimination strategy.

Is the HPV vaccine safe?

Yes. Gardasil 9 is a non-live vaccine that cannot cause HPV infection. Billions of doses have been delivered worldwide since 2006 and the vaccine has been extensively safety-monitored. Common side effects are mild: a sore arm at the injection site, a short-lived headache or low-grade fever lasting one to two days. Severe allergic reactions are extremely rare and managed by trained NHS immunisation teams. No serious safety concerns have emerged from long-term Scottish, UK or international monitoring data.

This article is informational only and does not replace personalised advice from your GP, pharmacist, or another qualified healthcare professional.